title: Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.
authors.forename: Sarita
authors.initials: S
authors.lastname: Nori
authors.forename: Chris
authors.initials: C
authors.lastname: Nebesio
authors.forename: Ryan
authors.initials: R
authors.lastname: Brashear
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Travers
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001372:Aza Compounds / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000150:complications / Q000209:etiology*; D017809:Fatal Outcome; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D017114:Liver Failure, Acute / Q000209:etiology*; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects*; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin